NovaBay Pharmaceuticals, Inc. announced that effective March 7, 2019, John J. McGovern, the Interim President and Chief Executive Officer, Chief Financial Officer and Treasurer of the Company resigned from such positions effective immediately. Effective March 8, 2019, the Board appointed Justin Hall, the company's Senior Vice President and General Counsel, as the Interim President and Chief Executive Officer of the company, replacing Mr. McGovern in these positions. Mr. Hall will serve as the Interim President and Chief Executive Officer until the company completes its search process for a successor President and Chief Executive Officer.

Mr. Hall will continue to serve as the General Counsel of the Company during the interim period. Mr. Hall has served as the Company's Senior Vice President and General Counsel since December 2015. Prior to this, he served as the Company's lead in-house counsel beginning in February 2013.

Effective March 8, 2019, the Board appointed Jason Raleigh, the Company's current Corporate Controller, as the Interim Chief Financial Officer and Treasurer, replacing Mr. McGovern from these positions. Mr. Raleigh will serve as the Interim Chief Financial Officer and Treasurer until the Company completes its search process for a successor Chief Financial Officer and Treasurer. Mr. Raleigh will continue to serve as the Corporate Controller of the Company during the interim period.

Mr. Raleigh has served as the Company's Corporate Controller since February 2016, where he oversees and manages the Company's accounting department and related functions. Prior to joining the Company, Mr. Raleigh worked as Assistant Controller (from July 2011 to February 2016) and Director of Financial Accounting (from July 2011 to October 2013) at Amyris Inc.